445180 Stock Chart & Stats
₩7260.00
-₩390.00(-5.10%)
―
--
Day’s Range― - ―
52-Week Range₩6,010.00 - ₩13,400.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)48.91K
Market Cap
₩124.79B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)7.4
Beta0.58
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding17,189,188
10 Day Avg. Volume40,514
30 Day Avg. Volume48,915
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1,784,140.97
Revenue Forecast (FY)₩10.00T>
445180 FAQ
What was Purit Co., Ltd.’s price range in the past 12 months?
Purit Co., Ltd. lowest stock price was ₩6010.00 and its highest was ₩13400.00 in the past 12 months.
What is Purit Co., Ltd.’s market cap?
Purit Co., Ltd.’s market cap is ₩124.79B.
When is Purit Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Purit Co., Ltd.’s earnings last quarter?
Currently, no data Available
Is Purit Co., Ltd. overvalued?
According to Wall Street analysts Purit Co., Ltd.’s price is currently Undervalued.
Does Purit Co., Ltd. pay dividends?
Purit Co., Ltd. does not currently pay dividends.
What is Purit Co., Ltd.’s EPS estimate?
Purit Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Purit Co., Ltd. have?
Purit Co., Ltd. has 17,189,188 shares outstanding.
What happened to Purit Co., Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Purit Co., Ltd.?
Currently, no hedge funds are holding shares in KR:445180
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Samil Pharmaceutical Co., Ltd.
―
Kyongbo Pharmaceutical Co., Ltd.
―
Dongbang Medical Co., Ltd.
―
Jeil Pharmaceutical Co. Ltd.
―
RecensMedical, Inc.
―